Scynexis plans to conduct $40 million at-the-market offering of stock

Agent Cowen and Co. to conduct offering, will be paid a 3% commission

By Devika Patel

Knoxville, Tenn., Nov. 17 – Scynexis Inc. arranged a $40 million at-the-market sales agreement with Cowen and Co., LLC, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Cowen will be paid a 3% commission.

Proceeds will be used for working capital and general corporate purposes, including research and development and capital expenditures.

The drug discovery and development company is based in Research Triangle Park, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.